Department of Cancer Epidemiology and Prevention Research, CancerControl Alberta, Alberta Health Services, Holy Cross Center, Room 514, Box ACB, 2210 2nd Street SW, Calgary, Alberta, T2S 3C3, Canada.
Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, VIC, Australia.
Int J Behav Nutr Phys Act. 2018 Mar 21;15(1):27. doi: 10.1186/s12966-018-0659-3.
BACKGROUND: Physical activity has emerged as an important lifestyle factor for primary prevention of numerous diseases, including postmenopausal breast cancer. No study to date has assessed the acute and long-term effects of year-long aerobic exercise programs differing in prescribed exercise volume on physical activity and sedentary time in postmenopausal women. Therefore, we aimed to examine the effects of two moderate-vigorous intensity exercise doses on total, light and moderate-vigorous intensity physical activity times, and sedentary time in postmenopausal women during the year-long intervention and one year later. METHODS: The Breast Cancer and Exercise Trial in Alberta (BETA) was a two-center, two-arm, 12-month randomized controlled trial that included 400 previously inactive postmenopausal women randomized to either 150 (MODERATE) or 300 (HIGH) minutes/week of aerobic exercise. Physical activity and sedentary time were assessed at baseline, 6- (intervention mid-point), 12- (prior to end of intervention) and 24-months (follow-up) with waist-mounted accelerometers (Actigraph GTX3®). Self-reported activity and sedentary time at baseline, 12- and 24-months was also assessed (Past Year Total Physical Activity Questionnaire and SIT-Q). Intention-to-treat analyses were conducted using linear mixed models and adjusted for baseline variables. RESULTS: Both physical activity interventions led to increases in objective and subjective measures of total and moderate-vigorous intensity/recreational physical activity time, coupled with decreases in sedentary time, at 6- and 12-months compared to baseline. Additionally, greater increases in accelerometry-derived total physical activity time at 6- and 12-months, and self-reported recreational activity time at 12-months, compared to baseline were noted in the HIGH versus MODERATE groups. Decreases in total, light and moderate-vigorous intensity physical activity time, and an increase in sedentary time, in both groups were noted at 24-months compared to 12-months. A decrease in light intensity physical activity time in both groups at 24-months compared to baseline was also noted. CONCLUSION: These findings have important health implications, suggesting that total physical activity time can be increased with greater volumes of prescribed exercise, but that additional support and resources could be used to promote the maintenance of these high levels of aerobic exercise participation following study completion. TRIAL REGISTRATION: clinicaltrials.gov identifier: NCT01435005 (BETA Trial). Registred September 15th 2011 (retrospectively registered).
背景:身体活动已成为预防多种疾病(包括绝经后乳腺癌)的重要生活方式因素。迄今为止,尚无研究评估在一年的干预期间和一年后,不同规定运动量的有氧锻炼计划对绝经后妇女的身体活动和久坐时间的急性和长期影响。因此,我们旨在研究两种中等强度到剧烈强度的运动剂量对绝经后妇女一年干预期间和一年后总、轻和中等强度到剧烈强度身体活动时间以及久坐时间的影响。 方法:艾伯塔省乳腺癌与运动试验(BETA)是一项为期 12 个月的、双中心、双臂的随机对照试验,共纳入 400 名先前不活跃的绝经后妇女,随机分为每周 150 分钟(中等)或 300 分钟(高)的有氧运动。身体活动和久坐时间使用腰部佩戴的加速度计(Actigraph GTX3®)在基线、6 个月(干预中点)、12 个月(干预结束前)和 24 个月(随访)进行评估。基线、12 个月和 24 个月还使用(过去一年总身体活动问卷和 SIT-Q)评估自我报告的活动和久坐时间。使用线性混合模型进行意向治疗分析,并根据基线变量进行调整。 结果:与基线相比,两种身体活动干预均导致 6 个月和 12 个月时客观和主观的总和中度到剧烈强度/娱乐性身体活动时间增加,同时久坐时间减少。此外,与中等强度组相比,高剂量组在 6 个月和 12 个月时的加速度计测量的总身体活动时间以及 12 个月时的自我报告娱乐性活动时间有更大的增加。与 12 个月相比,两组在 24 个月时的总、轻和中等强度到剧烈强度身体活动时间减少,久坐时间增加。与基线相比,两组在 24 个月时的轻强度身体活动时间也减少。 结论:这些发现具有重要的健康意义,表明可以通过增加规定的运动量来增加总身体活动时间,但在研究完成后,可能需要额外的支持和资源来促进保持这种高水平的有氧运动参与。 试验注册:clinicaltrials.gov 标识符:NCT01435005(BETA 试验)。于 2011 年 9 月 15 日注册(回顾性注册)。
Int J Behav Nutr Phys Act. 2018-3-21
BMC Cancer. 2014-12-6
Cancer Epidemiol Biomarkers Prev. 2019-8-5
J Cancer Surviv. 2019-5-29
Endocr Relat Cancer. 2015-10
Cochrane Database Syst Rev. 2020-7-17
Int J Behav Nutr Phys Act. 2020-3-4
World J Cardiol. 2016-10-26
BMC Public Health. 2016-8-30